New Nanoparticle to Help Researchers Study Angiogenesis

January 15, 2009 By Debra Kain

(PhysOrg.com) -- Adah Almutairi, Ph.D., assistant professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, is first author of a paper recently published in the Proceedings of the National Academy of Sciences (PNAS.) The work of Almutairi and her former colleagues at UC Berkeley, along with researchers from the Washington University School of Medicine, describes a novel synthetic nanoparticle developed for noninvasive imaging of angiogenesis.

Angiogenesis, or the formation of new blood vessels, plays an important role in many human diseases such as cancer or heart disease such as weakening of the heart muscle (cardiomyopathy) or thickening and hardening of the arteries (atherosclerosis). Nanotechnology has the potential to revolutionize the diagnosis and treatment of these disorders, and the research team has developed a biodegradable nanoprobe to target a biological marker known to modulate angiogenesis.

“One challenge of nanoparticles has been the difficulty in targeting where they go, because of the properties of size and structure,” said Almutairi. “Either they are unable to diffuse into tissue, because the nanoparticles are too large, or - if too small - they clear out of the system too rapidly.” The nanoparticles also have to be structurally camouflaged so they aren’t attacked by the system’s immune system.

The researchers designed a nanoprobe that is commercially viable because it is biodegradable and dissolves so has no long-term, toxic effect, according to Almutairi.

“This particle is small enough to easily circulate - about ten to 12 nanometers in size, where most nanoparticles are about 50 nanometers,” Almutairi said. “We also ‘decorated’ it with targeting groups in a novel way so that it can recognize diseased tissue.”

Most importantly, this nanoprobe has increased selectivity for cells that express a specific integrin receptor, αvβ3, which serves as a biological marker for angiogenesis. These adhesive receptors are critical for the proliferation, survival and function of new blood vessels.

Almutairi says she hopes to collaborate with cancer researchers who can use this nanoparticle in the development of new diagnostics and therapeutics.

Provided by University of California, San Diego

Explore further: Research reveals how advertisers play the online bidding game

Related Stories

Recommended for you

Reshaping the solar spectrum to turn light to electricity

July 28, 2015

When it comes to installing solar cells, labor cost and the cost of the land to house them constitute the bulk of the expense. The solar cells—made often of silicon or cadmium telluride—rarely cost more than 20 percent ...

Could stronger, tougher paper replace metal?

July 24, 2015

Researchers at the University of Maryland recently discovered that paper made of cellulose fibers is tougher and stronger the smaller the fibers get. For a long time, engineers have sought a material that is both strong (resistant ...

Changing the color of light

July 23, 2015

Researchers at the University of Delaware have received a $1 million grant from the W.M. Keck Foundation to explore a new idea that could improve solar cells, medical imaging and even cancer treatments. Simply put, they want ...

Wafer-thin material heralds future of wearable technology

July 27, 2015

UOW's Institute for Superconducting and Electronic Materials (ISEM) has successfully pioneered a way to construct a flexible, foldable and lightweight energy storage device that provides the building blocks for next-generation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.